Vinay Kumar Satla is a Senior Executive at SUN PHARMA, with a solid foundation in biotechnology and pharmaceuticals. They secured an M.S. in Pharmaceutical Sciences by research at the National Institute of Pharmaceutical Education and Research, focusing on the interaction of PON1 with lipoprotein. Vinay has held positions at Hetero Drugs Ltd as a Junior Research Associate and has experience as a Senior Executive at Syngene International. Their expertise spans various areas including biotech processing, clinical data management, and drug development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices